Stockreport

ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF Stephens analyst has initiated coverage on ADC Therapeutics SA (NYSE: ADCT ), a commercial-stage oncology-focused biotechnology company developing antibody-drug conjuga [Read more]